Dr. Agarwals Health Care Limited IPO is opening on 29 January 2025 and will run until 31 January 2025. This mainboard IPO will be raising ₹3027.26 crore from a mix of fresh issue of 75 lakh shares amounting to ₹300 crore and offer for sale of 6.78 crore shares amounting to ₹2727.26 crore.
The Dr. Agarwals Health Care IPO allotment date will be finalized on Monday, 3 February 2025. Dr. Agarwals Health Care shares will probably be listed on NSE and BSE on Wednesday, 5 February 2025.
Dr. Agarwals Health Care IPO’s price band has been set at ₹382 to ₹402 per share. The IPO lot size is 35 per application which makes the minimum retail investment ₹14070. For the sNII, the minimum investment is ₹211050 as they have to at least subscribe to 15 lots or 525 shares and bNII have to subscribe to at least 72 lot or 2520 shares amounting to ₹1013040.
Here Are the Quick Steps to Apply for the Dr. Agarwals Health Care IPO with the Best IPO App!
Dr. Agarwals Health Care NSE & BSE IPO Details
Detail | Information |
IPO Opening Date | January 29, 2025 |
IPO Closing Date | January 31, 2025 |
Tentative IPO Listing Date | February 3, 2025 |
Face Value | ₹1 per share |
Price Range | ₹382 to ₹402 per share |
Lot Size | 35 shares |
Total Issue Size | 75304970 (₹3027.26 Cr) |
Fresh Issue | 7462686 (₹300 Cr) |
OFS | 67842284 (₹2727.26 Cr) |
IPO Segment | Book Built Issue IPO |
Listing At | NSE & BSE |
Share Holding Pre-Issue | 308417160 shares |
Share Holding Post-Issue | 315879846 shares |
Dr. Agarwals Health Care Limited | Company Overview
Dr. Agarwals Health Care Limited is one of the most reputed eye care services across 117 cities 14 different states and four UTs. The services it offers include –
- Cataract surgeries
- Refractive surgeries
- Non-surgical treatments
- Diagnoses of eye problems
- Consultation
- Optical products
- Contact lenses
- Pharma products for eye-care
- Others
It uses robotics, and other advanced technology to perform the surgeries which help the patients have a smooth surgery and heal easily and quickly.
Dr. Agarwals Health Care Ltd. has already served over 2.13 million patients, which is an achievement in itself.
Want to subscribe to Dr. Agarwals Health Care Ltd. IPO with Best Investment App? Open a Demat Account Today!
Dr. Agarwals Health Care Limited IPO | Key Details
- Dr. Agarwals Health Care IPO Opening Date: January 29, 2025,
- Dr. Agarwals Health Care IPO Closing Date: January 31, 2025.
- Allotment Date: February 3, 2025
- Price Band: ₹382 to ₹ 402 per share
- Lot Size: 35 shares
- Refunds Initiated: February 4, 2025
- Shares Credited to Demat: February 4, 2025
- Listing Date: February 5, 2025
Dr. Agarwals Health Care Ltd: Financial Overview
Dr. Agarwals Health Care Limited had seen a loss of 7.92% in FY24 even though revenue rose by 33% during the period. However, the healthcare provider increased its reserve and surplus and net worth significantly.
Here are the details of the financials of the firm
Amounts in ₹ Crore
Financial Information | 31-Mar-24 | 31-Mar-23 | Change | Change (%) |
Assets | 2,752.82 | 1,825.17 | 927.65 | 50.82540257 |
Revenue | 1,376.45 | 1,031.49 | 344.96 | 33.4428836 |
Profit After Tax | 95.05 | 103.23 | -8.18 | -7.92405309 |
Net Worth | 1,337.68 | 627.83 | 709.85 | 113.064046 |
Reserve & Surplus | 1,365.86 | 652.63 | 713.23 | 109.2855063 |
Total Borrowing | 387.79 | 356.18 | 31.61 | 8.874726262 |
Dr. Agarwals Health Care Ltd IPO | FAQs
Dr. Agarwals Health Care Ltd is engaged in eye care services, from cataract surgeries to refractive surgeries, non-surgical treatments, and eyecare products.
The tentative IPO listing date of Dr. Agarwals Health Care has been fixed as Wednesday, February 5, 2025.
The bidding date for the Dr. Agarwals Health Care IPO is January 29, 2025, and it will continue until January 31 2025.
The minimum IPO lot size for Dr. Agarwals Health Care is 35 shares and for sNII, it is 15 lots and for bNII it is 72 lots.
The IPO allotment is expected to be finalized on Monday, February 3, 2025.
The IPO face value is set at ₹1 per share.
______________________________________________________________________________________
Disclaimer: Investments in the securities market are subject to market risks; read all the related documents carefully before investing.